Trichostatin A
VP-VTR-297-1101
Phase 1 small_molecule active
Quick answer
Trichostatin A for Relapsed or Refractory Hematologic Malignancies is a Phase 1 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Relapsed or Refractory Hematologic Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active